MCU and renal cell carcinoma: Similarly, the reduction of MCU expression in renal cell carcinoma, through the overexpression of the EF-hand domain family member D1 protein (EFHD1), and a negative regulator of MCU activity, leads to the reduction in cell migration and metastatic potential [76].